share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Secora Michael
美股SEC公告 ·  06/17 17:50

Moomoo AI 已提取核心訊息

Michael Secora, the Chief Financial Officer of Recursion Pharmaceuticals, completed a series of transactions involving the company's Class A Common Stock on June 13 and June 14, 2024. Secora acquired a total of 78,750 shares through the exercise of derivative securities at a price of $2.22 per share. Concurrently, he sold 30,000 shares in the open market, with sale prices ranging from $9.2721 to $9.3199 per share, resulting in a total market value of $278,880 for the disposed shares. Following these transactions, Secora's direct holdings in Recursion Pharmaceuticals amount to 1,267,843 shares of Class A Common Stock.
Michael Secora, the Chief Financial Officer of Recursion Pharmaceuticals, completed a series of transactions involving the company's Class A Common Stock on June 13 and June 14, 2024. Secora acquired a total of 78,750 shares through the exercise of derivative securities at a price of $2.22 per share. Concurrently, he sold 30,000 shares in the open market, with sale prices ranging from $9.2721 to $9.3199 per share, resulting in a total market value of $278,880 for the disposed shares. Following these transactions, Secora's direct holdings in Recursion Pharmaceuticals amount to 1,267,843 shares of Class A Common Stock.
藥品企業Recursion Pharmaceuticals的首席財務官Michael Secora於2024年6月13日和6月14日完成了一系列交易。Secora以每股2.22美元的價格行使衍生證券,共獲得78,750股。與此同時,他在公開市場上以每股9.2721美元至9.3199美元的價格出售30,000股,共計出售額爲278,880美元。在這些交易之後,Secora的Recursion Pharmaceuticals直接持有的A類普通股共計1,267,843股。
藥品企業Recursion Pharmaceuticals的首席財務官Michael Secora於2024年6月13日和6月14日完成了一系列交易。Secora以每股2.22美元的價格行使衍生證券,共獲得78,750股。與此同時,他在公開市場上以每股9.2721美元至9.3199美元的價格出售30,000股,共計出售額爲278,880美元。在這些交易之後,Secora的Recursion Pharmaceuticals直接持有的A類普通股共計1,267,843股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息